这是一篇来自已证抗体库的有关
人类 CYP24A1的综述，是根据10篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合CYP24A1 抗体。
CYP24A1 同义词: CP24; CYP24; HCAI; HCINF1; P450-CC24; 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial; 1,25-@dihydroxyvitamin D3 24-hydroxylase; 24-OHase; cytochrome P450 24A1; cytochrome P450, family 24, subfamily A, polypeptide 1; cytochrome P450, subfamily XXIV (vitamin D 24-hydroxylase); cytochrome P450-CC24; exo-mitochondrial protein; vitamin D 24-hydroxylase; vitamin D(3) 24-hydroxylase
赛信通（上海）生物试剂有限公司
| 兔 单克隆（D12B2） | | 赛信通（上海）生物试剂有限公司 CYP24A1抗体（Cell Signaling, 5724)被用于被用于免疫印迹在小鼠样品上浓度为1:1000 (图 4e). Nat Commun (2016) ncbi |
| 兔 单克隆（D12B2） | | 赛信通（上海）生物试剂有限公司 CYP24A1抗体（CST, 5724)被用于被用于免疫印迹在小鼠样品上 (图 4d). J Clin Invest (2017) ncbi |
| 兔 单克隆（D12B2） | | 赛信通（上海）生物试剂有限公司 CYP24A1抗体（Cell Signaling, 5724)被用于被用于免疫印迹在人类样品上 (图 2a, 2b, 2c). Oncotarget (2016) ncbi |
| 兔 单克隆（D12B2） | | 赛信通（上海）生物试剂有限公司 CYP24A1抗体（cell signalling, 5724)被用于被用于免疫印迹在人类样品上 (图 4c). Oncotarget (2016) ncbi |
| 兔 单克隆（D12B2） | | 赛信通（上海）生物试剂有限公司 CYP24A1抗体（Cell Signaling, 5724)被用于被用于免疫印迹在人类样品上 (图 3). Int J Cancer (2016) ncbi |
| 兔 单克隆（D12B2） | | 赛信通（上海）生物试剂有限公司 CYP24A1抗体（Cell Signaling Technology, 5724)被用于被用于免疫印迹在人类样品上 (图 6). Oncogene (2016) ncbi |
默克密理博中国
| 兔 多克隆 | | 默克密理博中国 CYP24A1抗体（Chemicon, AB1294)被用于被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200. PLoS ONE (2014) ncbi |
| 兔 多克隆 | | 默克密理博中国 CYP24A1抗体（Chemicon, AB1294)被用于被用于免疫组化在小鼠样品上浓度为1:200. Oncogene (2014) ncbi |
| 兔 多克隆 | | 默克密理博中国 CYP24A1抗体（Millipore, AB1294)被用于被用于免疫组化在小鼠样品上浓度为1:200. Cell Tissue Res (2013) ncbi |
西格玛奥德里奇
| 兔 多克隆 | | 西格玛奥德里奇 CYP24A1抗体（Sigma, HPA022261)被用于被用于免疫印迹在小鼠样品上浓度为1:1000. J Cell Physiol (2014) ncbi |
Aguilera T, Rafat M, Castellini L, Shehade H, Kariolis M, Hui A,
et al. Reprogramming the immunological microenvironment through radiation and targeting Axl. Nat Commun. 2016;7:13898
pubmed 出版商 Kariolis M, Miao Y, Diep A, Nash S, Olcina M, Jiang D,
et al. Inhibition of the GAS6/AXL pathway augments the efficacy of chemotherapies. J Clin Invest. 2017;127:183-198
pubmed 出版商 Park J, Lee C, Kim H, Kim D, Son J, Ko E,
et al. Suppression of the metastatic spread of breast cancer by DN10764 (AZD7762)-mediated inhibition of AXL signaling. Oncotarget. 2016;7:83308-83318
pubmed 出版商 Hsieh M, Yang P, Wong L, Lee J. The AXL receptor tyrosine kinase is associated with adverse prognosis and distant metastasis in esophageal squamous cell carcinoma. Oncotarget. 2016;7:36956-36970
pubmed 出版商 van der Mijn J, Broxterman H, Knol J, Piersma S, de Haas R, Dekker H,
et al. Sunitinib activates Axl signaling in renal cell cancer. Int J Cancer. 2016;138:3002-10
pubmed 出版商 Debruyne D, Bhatnagar N, Sharma B, Luther W, Moore N, Cheung N,
et al. ALK inhibitor resistance in ALK(F1174L)-driven neuroblastoma is associated with AXL activation and induction of EMT. Oncogene. 2016;35:3681-91
pubmed 出版商 Bach F, Rutten K, Hendriks K, Riemers F, Cornelissen P, de Bruin A,
et al. The paracrine feedback loop between vitamin D? (1,25(OH)?D?) and PTHrP in prehypertrophic chondrocytes. J Cell Physiol. 2014;229:1999-2014
pubmed 出版商 Cacioppo J, Oh S, Kim H, Cho J, Lin P, Yanagisawa M,
et al. Loss of function of endothelin-2 leads to reduced ovulation and CL formation. PLoS ONE. 2014;9:e96115
pubmed 出版商 Tripathi P, Wang Y, Coussens M, Manda K, Casey A, Lin C,
et al. Activation of NFAT signaling establishes a tumorigenic microenvironment through cell autonomous and non-cell autonomous mechanisms. Oncogene. 2014;33:1840-9
pubmed 出版商 Campbell L, Trendell J, Spears N. Identification of cells migrating from the thecal layer of ovarian follicles. Cell Tissue Res. 2013;353:189-94
pubmed 出版商
